Corvus Pharmaceuticals
CRVS
$1.58
Share price
8.97%
Change (1 day)
42.34%
Change (1 year)
Categories
EPS for Corvus Pharmaceuticals (CRVS)
EPS in 2023 (TTM): -$0.84
According to Corvus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$0.84. In 2022 the company made an earnings per share (EPS) of -$0.89 an increase over its 2021 EPS that were of -$1.06.
EPS history for Corvus Pharmaceuticals from 2015 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.84 | -5.62% |
| 2022 | -$0.89 | -16.04% |
| 2021 | -$1.06 | 404.76% |
| 2020 | -$0.21 | -86.79% |
| 2019 | -$1.59 | -9.14% |
| 2018 | -$1.75 | -35.66% |
| 2017 | -$2.72 | -60.47% |
| 2016 | -$6.88 | 348.05% |
| 2015 | -$1.54 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | 159.52% | 🇺🇸 USA |